PRLD's three largest insider shareholders as of June 02, 2026 are Advisors Llc Orbimed (Director, 10.12Mn shares), David P Bonita (Director, 10.12Mn shares), Krishna Vaddi (Ceo, 2.00Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Advisors Llc Orbimed | - | 0 | 10,119,756 | 24 May, 2023 |
| Laurent Chardonnet | Chief Financial Officer | 42,165 | 0 | 25 May, 2023 |
| David P Bonita | - | 0 | 10,119,756 | 24 May, 2023 |
| Jane Huang | President, Cmo | 86,917 | 0 | 07 Oct, 2025 |
| Bryant David Lim | Clo, Interim Cfo, Corp Sec. | 27,400 | 0 | 20 Dec, 2024 |
| Deborah Morosini | Evp, Chief Of Clinical Affairs | 444 | 0 | 17 Dec, 2021 |
| Christopher Pierce | Evp And Chief Of Business Oper | 3,750 | 0 | 07 Sep, 2021 |
| Peggy Scherle | Chief Scientific Officer | 172,920 | 0 | 30 Aug, 2021 |
| Krishna Vaddi | Ceo | 1,999,296 | 0 | 27 Mar, 2025 |
| Andrew Combs | Chief Chemistry Officer | 480,123 | 0 | 27 Mar, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 21 Apr, 2026 | Advisors Llc Orbimed | Common Stock | A | 1,689,189 | $4.44 | 11,808,945 | I | P |
| 21 Apr, 2026 | Advisors Llc Orbimed | Common Stock | A | 1,126,126 | $4.44 | 1,126,126 | I | P |
| 04 Feb, 2026 | Peggy Scherle | Employee Stock Option (right to buy) | A | 230,000 | $0.00 | 230,000 | D | A |
| 04 Feb, 2026 | Krishna Vaddi | Employee Stock Option (right to buy) | A | 837,000 | $0.00 | 837,000 | D | A |
| 04 Feb, 2026 | Krishna Vaddi | Employee Stock Option (right to buy) | A | 837,000 | $0.00 | 837,000 | D | A |
| 04 Feb, 2026 | Andrew Combs | Employee Stock Option (right to buy) | A | 230,000 | $0.00 | 230,000 | D | A |
| 04 Feb, 2026 | Peggy Scherle | Employee Stock Option (right to buy) | A | 230,000 | $0.00 | 230,000 | D | A |
| 04 Feb, 2026 | Peggy Scherle | Employee Stock Option (right to buy) | A | 230,000 | $0.00 | 230,000 | D | A |
| 04 Feb, 2026 | Bryant David Lim | Employee Stock Option (right to buy) | A | 275,000 | $0.00 | 275,000 | D | A |
| 04 Feb, 2026 | Krishna Vaddi | Employee Stock Option (right to buy) | A | 837,000 | $0.00 | 837,000 | D | A |
| 05 Nov, 2025 | Victor Sandor | Director Stock Option (Right to Buy) | A | 121,285 | $0.00 | 121,285 | D | A |
| 05 Nov, 2025 | Victor Sandor | Director Stock Option (Right to Buy) | A | 121,285 | $0.00 | 121,285 | D | A |
| 05 Nov, 2025 | Victor Sandor | Director Stock Option (Right to Buy) | A | 121,285 | $0.00 | 121,285 | D | A |
| 17 Oct, 2025 | Katina Dorton | Director Stock Option (Right to Buy) | A | 76,000 | $0.00 | 76,000 | D | A |
| 04 Oct, 2025 | Jane Huang | Common Stock | A | 9,375 | - | 90,272 | D | M |
| 04 Oct, 2025 | Jane Huang | Common Stock | D | 3,355 | $1.47 | 86,917 | D | F |
| 04 Oct, 2025 | Jane Huang | Restricted Stock Unit | D | 9,375 | $0.00 | 18,750 | D | M |
| 04 Jul, 2025 | Jane Huang | Common Stock | A | 9,375 | - | 84,252 | D | M |
| 04 Jul, 2025 | Jane Huang | Common Stock | D | 3,355 | $0.79 | 80,897 | D | F |
| 04 Jul, 2025 | Jane Huang | Restricted Stock Unit | D | 9,375 | $0.00 | 28,125 | D | M |